Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease

BACKGROUND: Perceived risks of hyperkalemia and acute renal insufficiency may limit use of mineralocorticoid receptor antagonist (MRA) therapy in patients with heart failure, especially those with diabetes mellitus or chronic kidney disease. METHODS AND RESULTS: Using clinical registry data linked t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Cooper, Lauren B., Lippmann, Steven J., Greiner, Melissa A., Sharma, Abhinav, Kelly, Jacob P., Fonarow, Gregg C., Yancy, Clyde W., Heidenreich, Paul A., Hernandez, Adrian F.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5779000/
https://ncbi.nlm.nih.gov/pubmed/29275368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006540
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados